Published: 14 February 2023
Author(s): Christian Meinhardt, Stephan List, Alexander Elias Chamieh, Hinrich Fehrendt, Volker Meves, Moustafa Mohamed, Julian Müller, Thomas Deneke, Claudia Geismann, Albrecht Elsässer, Alexander Arlt, Philipp Halbfass
Issue: May 2023
Section: Original article

Atrial fibrillation (AF) represents the most common cardiac arrhythmia. It is associated with a 1.5- to 3.5-fold increase in mortality in conjunction with accompanying heart failure and other cardiovascular events [1]. Catheter ablation of AF including pulmonary vein isolation (PVI) has proven to be a safe and effective therapy evaluated in numerous trials [2]. In rare cases devastating complications like ablation-induced esophageal perforation or atrioesophageal fistula can occur, reported in ≤ 0.2% of AF ablation cases [3].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.